Hypovolemia
- Human trial2
- Humans1
Latest
1 in 12 monthsBiochemistry and Biophysics Reports
Distinct metabolomic signatures of SGLT2 inhibitor vs. sulfonylurea in a paired human liver biopsy study
Randomised trial in peopleInterventions
ENDO 2025 Abstract
MON-306 Effects of Dapagliflozin on Blood Pressure and Glycemic Control in Patients with Type 2 Diabetes on Combination Antihypertensive Therapy: A Systematic Review and Meta-Analysis
Meta-analysis of studies in peopleDapagliflozin
ENDO 2025 Abstract
MON-230 Safety Profile of Sodium-Glucose Cotransport-2 Inhibitors in a Large, Children’s Hospital System
Cohort study of 32 peopleSGLT2 inhibitors
Diabetes Care
Efficacy and Safety of Dapagliflozin in the Elderly: Analysis From the DECLARE-TIMI 58 Study
Randomised trial in 17,160 peopleDapagliflozin